Bioharvest Sciences Inc. BHST US Equity☆

Bioharvest Sciences Inc. (Nasdaq: BHST), an SEC filer in Pharmaceutical Preparations, closed at $1.84, -0.5%, on 2026-08-28, with a market cap of $42M as of 2026-08-27, a return on equity of -83.2% and a net margin of -32.3%. Institutional ownership, earnings history and filed financials are on the tabs below.

Item 3 and Item 9A are read from original 10-Ks. Foreign filers (20-F / ESEF / EDINET) file none, so this read covers US SEC filers.